Table 3 The application of TEXs in clinical diagnosis
From: Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
TEX-molecule | Type of cancer | TEXs source | Application | Refs |
|---|---|---|---|---|
CD63 | Melanoma | Plasma | Diagnosis and prognosis | [129] |
Caveolin-1 | ||||
GPC1 | Pancreatic cancer | Serum | Early diagnosis | [130] |
miR-373 | Triple-negative breast cancer | Serum | Diagnosis and prognosis | [133] |
miR-1290 | Prostate cancer | Plasma | Therapy monitoring | [134] |
miR-375 | ||||
miR-19a | Colorectal cancer | Serum | Prognosis | [134] |
let-7a | AML | Serum | Early diagnosis | [135] |
miR-99b | ||||
miR-146a | ||||
miR-155 | ||||
miR-191 | ||||
miR-1246 | ||||
miR-141 | Prostate cancer | Serum | Early diagnosis | [136] |
lncRNA CRNDE-p | Colorectal cancer | Serum | Diagnosis and prognosis | [137] |
miR-217 | ||||
lncRNA HOTAIR | Cervical cancer | Cervicovaginal Lavage Samples | Early diagnosis | [138] |
lncRNA MALAT1 | ||||
lncRNA MEG3 | ||||
miR-21 | Lung cancer | Serum | Early diagnosis | [139] |
lncRNA HOTAIR | ||||
lncRNA ZFAS1 | Gastric cancer | Serum | Early diagnosis | [140] |
circ-KLDHC10 | Colorectal cancer | Serum | Early diagnosis | [37] |